Companies: 10,795·Total market cap: $144.5T
CM Life Sciences III Inc.

CM Life Sciences III Inc.

CMLTNASDAQFinancial Services
$8.69
$-0.52(-5.65%)
Market Cap$4.2B
P/E Ratio—
52W High$9.17
52W Low$8.29
SEC Filings

CM Life Sciences III Inc. (CMLT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001843762 · CMLT · NASDAQ · as of Jun 8, 2026

Filing snapshot

233
Total Filings
15-12G
Latest Form
2023-11-20
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001843762 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-02-23
Fiscal Year End
Feb 23, 2023
Accession No.
0001558370-23-001902
Primary Document
eqrx-20221231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001843762 · Accession 0001558370-23-001902

Latest Key Filings

10-QQuarterly Report
10-Q
2023-11-06
View 10-Q on SEC
8-KCurrent Report
8-K
2023-11-09Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2023-11-20
View
EFFECTEFFECT
EFFECT
2023-11-17
View
EFFECTEFFECT
EFFECT
2023-11-17
View
EFFECTEFFECT
EFFECT
2023-11-17
View
SC 13G/ABeneficial Ownership Report (Amended)
ARCH VENTURE FUND X, L.P. - EQRX, INC. -- SCH 13G/A(#1E)
2023-11-17
View
SC 13D/ASC 13D/A
SC 13D/A
2023-11-17
View
SC 13D/ASC 13D/A
SC 13D/A
2023-11-15
View
SC 13D/ASC 13D/A
SC 13D/A
2023-11-15
View
POS AMPOS AM
POS AM
2023-11-09
View
POS AMPOS AM
POS AM
2023-11-09
View
S-8 POSS-8 POS
S-8 POS
2023-11-09
View
S-8 POSS-8 POS
S-8 POS
2023-11-09
View
POS AMPOS AM
POS AM
2023-11-09
View
25-NSE25-NSE
25-NSE
2023-11-09
View
8-KCurrent Report
8-K
2023-11-09
View
Showing 1–15 of 177 filingsForm 4 / 144 hidden· 233 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001843762  |  Exchange: NASDAQ · Financial Services

CM Life Sciences III Inc. (NASDAQ: CMLT) has submitted 233 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Financial Services sector company with CIK 0001843762, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is CM Life Sciences III Inc.'s most comprehensive regulatory disclosure. The most recent CM Life Sciences III Inc. 10-K was filed on 2023-02-23 for fiscal year ending 2023. Historical CMLT 10-K annual reports are available from 2021 through 2023.

Investors researching CM Life Sciences III Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Financial Services
VGAC SEC Filings →GHVI SEC Filings →GRNV SEC Filings →FRX SEC Filings →HOL SEC Filings →THCB SEC Filings →CMII SEC Filings →PAYO SEC Filings →
→ CMLT Financials→ CMLT Earnings→ CMLT Insider Trades

Frequently Asked Questions

CMLT SEC Filings · 8 questions

CM Life Sciences III Inc. (CMLT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 233 filings and access original documents at no cost. CM Life Sciences III Inc.'s CIK is 0001843762.

CMLT SEC filingsCM Life Sciences III Inc. SEC documentsfind CMLT 10-K